ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,90
0,00%
Dow Jones
44 593,65
0,28%
DAX
22 037,83
0,48%
Brent Oil
76,555
-0,10%
Bitcoin
95 886,30
0,14%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PMGC Holdings Inc (ELAB)

  7. PMGC Holdings Inc (ELAB) Actualités

ELAB

PMGC (ELAB)

PMGC Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ELAB
DateHeureSourceTitreSymboleSociété
10/02/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELABPMGC Holdings Inc
07/02/202522h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELABPMGC Holdings Inc
04/02/202514h00GlobeNewswire Inc.Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1NASDAQ:ELABPMGC Holdings Inc
31/01/202522h19Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELABPMGC Holdings Inc
31/01/202516h33GlobeNewswire Inc.PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology CompaniesNASDAQ:ELABPMGC Holdings Inc
30/01/202514h00GlobeNewswire Inc.Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1NASDAQ:ELABPMGC Holdings Inc
27/01/202515h00GlobeNewswire Inc.PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional InvestorsNASDAQ:ELABPMGC Holdings Inc
27/01/202512h03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELABPMGC Holdings Inc
24/01/202514h00GlobeNewswire Inc.Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity SymposiumNASDAQ:ELABPMGC Holdings Inc
16/01/202514h31GlobeNewswire Inc.PMGC Holdings Inc. Announces Closing of Elevai Skincare DivestitureNASDAQ:ELABPMGC Holdings Inc
15/01/202515h30GlobeNewswire Inc.PMGC Holdings Inc. Announces Name Change of Wholly Owned SubsidiariesNASDAQ:ELABPMGC Holdings Inc
02/01/202521h55GlobeNewswire Inc.PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth StrategyNASDAQ:ELABPMGC Holdings Inc
02/01/202514h00GlobeNewswire Inc.Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care ProductsNASDAQ:ELABPMGC Holdings Inc
21/12/202401h30GlobeNewswire Inc.Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to NevadaNASDAQ:ELABPMGC Holdings Inc
20/12/202413h30GlobeNewswire Inc.Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to NevadaNASDAQ:ELABPMGC Holdings Inc
09/12/202414h00GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle PreservationNASDAQ:ELABPMGC Holdings Inc
06/12/202413h30GlobeNewswire Inc.Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care MarketNASDAQ:ELABPMGC Holdings Inc
04/12/202414h00GlobeNewswire Inc.Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare DivisionNASDAQ:ELABPMGC Holdings Inc
25/11/202423h18Edgar (US Regulatory)Form DEFR14C - Revised information statement materials, definitiveNASDAQ:ELABPMGC Holdings Inc
23/11/202400h23GlobeNewswire Inc.Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing ComplianceNASDAQ:ELABPMGC Holdings Inc
22/11/202423h11Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:ELABPMGC Holdings Inc
22/11/202423h00GlobeNewswire Inc.Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to ReassessNASDAQ:ELABPMGC Holdings Inc
22/11/202414h11Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:ELABPMGC Holdings Inc
14/11/202420h35GlobeNewswire Inc.CORRECTION - Elevai Labs Inc.NASDAQ:ELABPMGC Holdings Inc
14/11/202415h08GlobeNewswire Inc.Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business UpdateNASDAQ:ELABPMGC Holdings Inc
04/11/202423h45GlobeNewswire Inc.Elevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNASDAQ:ELABPMGC Holdings Inc
22/10/202415h54GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of ObesityNASDAQ:ELABPMGC Holdings Inc
21/10/202413h30GlobeNewswire Inc.Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of ObesityNASDAQ:ELABPMGC Holdings Inc
04/10/202423h26Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:ELABPMGC Holdings Inc
04/10/202423h08GlobeNewswire Inc.Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred StockNASDAQ:ELABPMGC Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ELAB

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
EU
CS
Axa
COIN
ETHUSD
Ethereum
EU
BN
Danone
EU
AF
Air FranceKLM
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
EU
BNP
BNP Paribas
NYSE
MRK
Merck
EU
PX1
CAC 40
FTSE
UKX
FTSE 100
EU
RI
Pernod Ricard
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces